Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Q2 2025 Management View CEO Al Carey noted that Q2 revenues were consistent with recent quarters yet slightly below projections due to sluggish sales in North America and Asia. However, green shoots ...

Inc. reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.31, slightly above the forecast of $2.30. The company's ...

GOKONGWEI-LED Robinsons Retail Holdings Inc. (RRHI) on Thursday reported core earnings of P6.3 billion for 2024, an increase of 12.3 percent from P5.64 billion a year earlier, driven by higher gross ...

Shares of Philip Morris International are on track for an all-time closing high, after the company reported strong sales growth for its Marlboro cigarettes and Zyn nicotine pouches. The tobacco c ...

With gains of just over 12% last year, Microsoft stock underperformed not only other “Magnificent 7” constituents but also the S&P 500 Index . 2025 hasn’t looked good for th ...

The company said that on a standalone basis, it reported its highest-ever revenue for the first nine months of the financial ...

Sweden's Volvo Cars, owned by China's Geely Group, said Thursday that annual profits rose in 2024 despite a final quarter ...

ICICI Securities recommended hold rating on Zydus Lifesciences with a target price of Rs 1000 in its research report dated.

Explore how businesses are innovating with AI in India and read Microsoft's initiatives to accelerate AI adoption.